Trials / Unknown
UnknownNCT05165615
Android Artificial Pancreas System (Android APS) Versus Control-IQ
Comparison of the Two Different Closed-loop Hybrid Systems - AndroidAPS and Control-IQ in Patients With Type 1 Diabetes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Charles University, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the investigator's study is to compare two different closed loop hybrid systems - certified Control-IQ and noncertified AndroidAPS in adult patients with Type 1 Diabetes (T1D), who had been using AndroidAPS previously from their own decision, during 12 weeks of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Insulin Pump t:slim X2 with Control-IQ technology | Usage of Insulin pump t:slim X2 with Control-IQ technology in previous users of AndroidAPS |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-06-30
- Completion
- 2022-12-31
- First posted
- 2021-12-21
- Last updated
- 2021-12-21
Locations
1 site across 1 country: Czechia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05165615. Inclusion in this directory is not an endorsement.